Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

IntroductionmRNA coronavirus disease 2019 (COVID-19) vaccination has been widely used to arrest the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Rarely, autoimmune events such as relapses in patients with multiple sclerosis (MS) have been reported after vaccin...

Full description

Bibliographic Details
Main Authors:	Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, Carmen Alcalá, María Payá, Javier Mallada, Raquel Silla, Sara Carratalà-Boscà, Raquel Gasque-Rubio, Jessica Castillo, Bonaventura Casanova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Neurology
Subjects:	mRNA COVID-19 vaccine vaccination multiple sclerosis relapses exacerbation (symptom flare up)
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.897275/full

Similar Items

Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)
by: Fardin Nabizadeh, et al.
Published: (2023-01-01)

Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis–A case series and mini review
by: Sascha Ständer, et al.
Published: (2022-09-01)

Generalized Pustular Psoriasis Flare-Up after Both Doses of BBIBP-CorV Vaccination in a Patient under Adalimumab Treatment: A Case Report
by: Dorsa Dayani, et al.
Published: (2023-04-01)

Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case Report
by: Giulia Costanzo, et al.
Published: (2021-12-01)

Clinical evaluation of a sub-lingual vaccine for prevention of exacerbations in COPD
by: P.D. Nadig
Published: (2016-02-01)

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
by: Luca Potestio, et al.
Published: (2023-08-01)

Management of acute exacerbations in multiple sclerosis
by: Ontaneda Daniel, et al.
Published: (2009-01-01)

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination
by: Saori Amiya, et al.
Published: (2022-03-01)

The Flares of Low back pain with Activity Research Study (FLAReS): study protocol for a case-crossover study nested within a cohort study
by: Pradeep Suri, et al.
Published: (2022-04-01)

Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters
by: Emmanouil Karampinis, et al.
Published: (2024-02-01)

Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report
by: Simon Moubarak, et al.
Published: (2023-01-01)

Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
by: Warren Fong, et al.
Published: (2023-08-01)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
by: Qasim H, et al.
Published: (2023-04-01)

Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males – Case reports
by: Donato Amodio, et al.
Published: (2023-08-01)

Outcomes of AstraZeneca vaccine for relapse and Covid-19 infection in people with multiple sclerosis
by: Nazanin Razazian, et al.
Published: (2022-09-01)

Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
by: Nicole Armbruster, et al.
Published: (2019-09-01)

Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study
by: Tal Gazitt, et al.
Published: (2023-02-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
by: Reese Jalal Ladak, et al.
Published: (2022-05-01)

Associations Between Asthma Diagnosis/Asthma Exacerbation and Previous Proton-Pump Inhibitor use: A Nested Case-Control Study Using a National Health Screening Cohort
by: Hyo Geun Choi, et al.
Published: (2022-06-01)

Impact of pneumococcal vaccine response on asthma exacerbation frequency in young children
by: Claudia P. Eisenlohr, et al.
Published: (2020-12-01)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
by: Giorgia T. Maniscalco, et al.
Published: (2021-08-01)

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
by: Antonia Pignolo, et al.
Published: (2021-12-01)

Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
by: Nusrat Zahan Rouf, et al.
Published: (2022-12-01)

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare
by: Tatsuo Kanda, et al.
Published: (2023-01-01)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2022-11-01)

Risk of Exacerbation of Rheumatic Disease after COVID-19 Vaccination
by: Amy Cheung Chung Ting, et al.
Published: (2023-07-01)

Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination
by: Marialuisa Bocchino, et al.
Published: (2022-01-01)

The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
by: Mohammad Balabandian, et al.
Published: (2024-01-01)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines [Letter]
by: Ali A, et al.
Published: (2023-06-01)

Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series
by: Timothy L. Cowan, et al.
Published: (2023-01-01)

Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center
by: Yi-Wei Huang, et al.
Published: (2021-12-01)

Clinical and pharmacological management of endodontic flare-up
by: Harikaran Jayakodi, et al.
Published: (2012-01-01)

Acute exacerbations of COPD: risk factors for failure and relapse
by: Mantero M, et al.
Published: (2017-09-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
by: Alexey D. Perenkov, et al.
Published: (2023-10-01)

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report
by: Federica Calò, et al.
Published: (2022-06-01)

Darier’s Disease Flare following COVID-19 Vaccine
by: Mette Vestergaard Elbæk, et al.
Published: (2021-08-01)

There Is No Evidence That Inactivated COVID-19 Vaccines Increase Risks of Uveitis Flare
by: Hang Song, et al.
Published: (2022-10-01)

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
by: Hana Qasim, et al.
Published: (2021-01-01)

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
by: Ditz B, et al.
Published: (2021-11-01)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
by: Cristina Ramo-Tello, et al.
Published: (2021-12-01)